Cargando…

Complement 5a is an indicator of significant fibrosis and earlier cirrhosis in patients chronically infected with hepatitis B virus

PURPOSE: To investigate the association between serum complement 5a (C5a) concentration and liver fibrosis and cirrhosis in a large cohort of patients chronically infected with hepatitis B virus (HBV). METHODS: Five hundred and eight patients with chronic HBV infection undergoing liver biopsy were i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Yongqiong, Zhao, Hong, Zhou, Jiyuan, Yan, Linlin, Wang, Guiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306372/ https://www.ncbi.nlm.nih.gov/pubmed/27605044 http://dx.doi.org/10.1007/s15010-016-0942-7

Ejemplares similares

Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT
por: Yan, Linlin, et al.
Publicado: (2018)

Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT
por: Deng, Yongqiong, et al.
Publicado: (2017)

Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis
por: Qi, Xiaolong, et al.
Publicado: (2018)

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022)

Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection
por: Mak, Lung-Yi, et al.
Publicado: (2018)

Validation of three noninvasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis C in Saudi Arabia
por: Abdo, Ayman A., et al.
Publicado: (2007)

Impact of age on the diagnostic performances and cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in chronic hepatitis B
por: Li, Qiang, et al.
Publicado: (2017)

A Note on the Fibrosis of Hepatic Cirrhosis
por: Rolleston, H. D.
Publicado: (1897)

The Significant Morbidity and Mortality Indicators in Patients of Cirrhosis
por: Mallik, Manaswinee, et al.
Publicado: (2022)

Efficacy evaluation of direct antiviral drugs against hepatitis B virus in improving the degree of liver fibrosis
por: Miao, Liang, et al.
Publicado: (2023)

Prevalence of liver fibrosis and cirrhosis in 699 Moroccan patients with chronic hepatitis C
por: Bouayad, Abdellatif, et al.
Publicado: (2021)

Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis
por: Li, Xu, et al.
Publicado: (2019)

Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis
por: Loureiro, Dimitri, et al.
Publicado: (2023)

Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosis
por: Chen, Sheng-Sen, et al.
Publicado: (2016)

Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1α/VEGF signaling in systemic sclerosis
por: Mao, Jing, et al.
Publicado: (2022)

Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection
por: Yan, Li-Ting, et al.
Publicado: (2020)

Assessment of serology and spirometry and the combination of both to complement microbiological isolation for earlier detection of Pseudomonas aeruginosa infection in children with cystic fibrosis
por: Kotnik Pirš, Ana, et al.
Publicado: (2016)

Evaluation of eLIFT for Non-invasive Assessment of Liver fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Virus Infection
por: Li, Qiang, et al.
Publicado: (2017)

Prognostic indicators in primary biliary cirrhosis: significance of revised IAHG (International Autoimmune Hepatitis Group) score
por: Jung, Ho Eun, et al.
Publicado: (2012)

Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
por: Zhou, Jiyuan, et al.
Publicado: (2017)

Differential expression and significance of 5-hydroxymethylcytosine modification in hepatitis B virus carriers and patients with liver cirrhosis and liver cancer
por: Li, Yue-Cui, et al.
Publicado: (2023)

RDW to Platelet Ratio: A Novel Noninvasive Index for Predicting Hepatic Fibrosis and Cirrhosis in Chronic Hepatitis B
por: Chen, Baode, et al.
Publicado: (2013)

Atherosclerosis in chronic hepatitis C virus patients with and without liver cirrhosis
por: Barakat, Ashraf Abd El-Khalik, et al.
Publicado: (2017)

Predictive Factors in the Incidence of Cirrhosis in Chronic Hepatitis B Virus Infections
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

Guidelines for Prevention and Treatment of Chronic Hepatitis B
por: Wang, Guiqiang, et al.
Publicado: (2021)

Prognostic Value of Inflammatory Indicators in Chronic Hepatitis B Patients With Significant Liver Fibrosis: A Multicenter Study in China
por: Zhang, Xiujuan, et al.
Publicado: (2021)

Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus
por: Tachi, Yoshihiko, et al.
Publicado: (2015)

Treatment of Hepatitis B Virus Cirrhosis
por: Rizzetto, Mario
Publicado: (2012)

Etiology of liver cirrhosis in Brazil: chronic alcoholism and hepatitis viruses in liver cirrhosis diagnosed in the state of Espírito Santo
por: Gonçalves, Patricia Lofego, et al.
Publicado: (2013)

Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review
por: Khan, Shahbaz, et al.
Publicado: (2021)

Complement C3 Facilitates Stratification of Stages of Chronic Hepatitis B and Signifies Development of Acute-on-Chronic Liver Failure in Acute Decompensated Cirrhosis
por: Chen, Chong, et al.
Publicado: (2023)

Previous hepatitis E virus infection, cirrhosis and insulin resistance in patients with chronic hepatitis C
por: Bricks, Guilherme, et al.
Publicado: (2019)

Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients
por: Anadol, Evrim, et al.
Publicado: (2018)

The Significance of the Takata-Ara Reaction in the Diagnosis and Prognosis of Hepatic Cirrhosis
por: Pai, M. Narayana
Publicado: (1941)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C
por: Appourchaux, Kevin, et al.
Publicado: (2016)

Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B
por: Tsuji, Yuki, et al.
Publicado: (2020)

Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients
por: Li, Xu, et al.
Publicado: (2017)

Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients
por: Li, Xu, et al.
Publicado: (2019)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q1crb8rlhpl8oav3kgg6ejd4pl